Surgery Partners
SGRY
199 hedge funds and large institutions have $3.28B invested in Surgery Partners in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 65 reducing their positions, and 32 closing their positions.
108% more call options, than puts
Call options by funds: $96.8M | Put options by funds: $46.5M
5.49% more ownership
Funds ownership: 112.6% → 118.09% (+5.5%)
5% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 65
2% more capital invested
Capital invested by funds: $3.21B → $3.28B (+$68.7M)
0% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 32
1% less funds holding
Funds holding: 201 → 199 (-2)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$104M |
| 2 |
KSCM
King Street Capital Management
New York
|
+$69.5M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$27.7M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$22.7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$22.1M |
Top Sellers
SGRY Hedge Fund Activity: Q3 2025 in Review
199 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q3 2025, worth a combined $3.28B — up 2.1% from $3.21B a quarter earlier.
Fund positioning in SGRY was balanced in Q3 2025: 32 funds opened new positions, 32 closed out, 68 added to existing stakes and 65 trimmed.
The largest buyer was Pentwater Capital Management, adding an estimated $104M. The largest seller was Farallon Capital Management, cutting an estimated $23.5M.
- 199 institutional investors held Surgery Partners (SGRY) as of Q3 2025, down from 201 in Q2 2025.
- Funds reported $3.28B of Surgery Partners stock for Q3 2025, up 2.1% quarter-over-quarter.
- 32 funds opened new Surgery Partners positions in Q3 2025 and 32 closed out, a net change of 0 holders.
- The largest Surgery Partners buyer in Q3 2025 was Pentwater Capital Management, an estimated $104M added.
- The largest Surgery Partners seller in Q3 2025 was Farallon Capital Management, an estimated $23.5M sold.
Based on aggregated 13F filings for Q3 2025.